Vitreous cryopreservation maintains the function of vascular grafts.
Avoidance of ice formation during cooling can be achieved by vitrification, which is defined as solidification in an amorphous glassy state that obviates ice nucleation and growth. We show that a vitrification approach to storing vascular tissue results in markedly improved tissue function compared with a standard method involving freezing. The maximum contractions achieved in vitrified vessels were >80% of fresh matched controls with similar drug sensitivities, whereas frozen vessels exhibited maximal contractions below 30% of controls and concomitant decreases in drug sensitivity. In vivo studies of vitrified vessel segments in an autologous transplant model showed no adverse effects of vitreous cryopreservation compared with fresh tissue grafts.
Song
Y C
YC
Organ Recovery Systems, Inc., 701 East Bay Street, Charleston SC 29403, USA.
Khirabadi
B S
BS
Lightfoot
F
F
Brockbank
K G
KG
Taylor
M J
MJ
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001807:Blood Vessel Prosthesis; D001808:Blood Vessels / Q000637:transplantation*; D001920:Bradykinin / Q000494:pharmacology; D015925:Cryopreservation / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D007601:Jugular Veins / Q000033:anatomy & histology / Q000637:transplantation; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits; D013696:Temperature; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014680:Veins / Q000033:anatomy & histology / Q000637:transplantation
D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D006632:Histamine; D001920:Bradykinin; D009638:Norepinephrine